These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1316420)

  • 1. Role of PAF and cytokines in microvascular tissue injury.
    Koltai M; Hosford D; Braquet P
    J Lab Clin Med; 1992 May; 119(5):461-6. PubMed ID: 1316420
    [No Abstract]   [Full Text] [Related]  

  • 2. PAF-cytokine autocatalytic feed-back network in septic shock: involvement in acute renal failure.
    Koltai M; Pirotzky E; Braquet P
    Nephrol Dial Transplant; 1994; 9 Suppl 4():69-72. PubMed ID: 7800272
    [No Abstract]   [Full Text] [Related]  

  • 3. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.
    Gómez-Chiarri M; Ortíz A; Lerma JL; López-Armada MJ; Mampaso F; González E; Egido J
    Lab Invest; 1994 Apr; 70(4):449-59. PubMed ID: 8176885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 5. PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists.
    Koltai M; Hosford D; Braquet P
    J Lipid Mediat; 1993; 6(1-3):183-98. PubMed ID: 8357981
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent progress in ginkgolide research.
    Braquet P; Esanu A; Buisine E; Hosford D; Broquet C; Koltai M
    Med Res Rev; 1991 May; 11(3):295-355. PubMed ID: 1647474
    [No Abstract]   [Full Text] [Related]  

  • 7. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021.
    Touvay C; Vilain B; Taylor JE; Etienne A; Braquet P
    Prog Lipid Res; 1986; 25(1-4):277-88. PubMed ID: 2827186
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
    Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
    J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor antagonists as therapeutic strategy in sepsis.
    Dhainaut JF; Mira JP; Brunet F
    Prog Clin Biol Res; 1994; 388():277-93. PubMed ID: 7831364
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of platelet-activating factor in hepatocellular Ca2+ alterations during hemorrhagic shock.
    Silomon M; Pizanis A; Larsen R; Rose S
    J Surg Res; 1997 Oct; 72(2):101-6. PubMed ID: 9356229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist.
    Doly M; Bonhomme B; Braquet P; Chabrier PE; Meyniel G
    Immunopharmacology; 1987 Jun; 13(3):189-94. PubMed ID: 3038784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of long-term potentiation in the CA1 area of rat hippocampus by platelet-activating factor.
    Kato K
    Adv Exp Med Biol; 1999; 469():221-7. PubMed ID: 10667334
    [No Abstract]   [Full Text] [Related]  

  • 13. Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response.
    Maestre C; Zarco P; Gómez-Guerrero C; González E; Herrero-Beaumont G; Braquet M; Egido J
    J Lipid Mediat; 1990; 2 Suppl():S151-9. PubMed ID: 1966813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of the thrombocyte-activating factor in the development of circulatory disorders in the postischemic shock reaction].
    Sagach VF; Dmitrieva AV
    Fiziol Zh (1978); 1990; 36(4):8-14. PubMed ID: 2172032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence.
    Kubes P; Ibbotson G; Russell J; Wallace JL; Granger DN
    Am J Physiol; 1990 Aug; 259(2 Pt 1):G300-5. PubMed ID: 2166441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin shock, kinin system and PAF-acether in the rat.
    Damas J; Remacle-Volon G; Adam A; Bourdon V
    Adv Exp Med Biol; 1989; 247B():547-52. PubMed ID: 2610092
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists.
    Vogensen SB; Strømgaard K; Shindou H; Jaracz S; Suehiro M; Ishii S; Shimizu T; Nakanishi K
    J Med Chem; 2003 Feb; 46(4):601-8. PubMed ID: 12570381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shock.
    Bonavida B; Paubert-Braquet M; Hosford D; Braquet P
    Prog Clin Biol Res; 1989; 308():485-9. PubMed ID: 2780710
    [No Abstract]   [Full Text] [Related]  

  • 19. PAF-receptor. 1. 'Cache-oreilles' effect of selected high-potency platelet-activating factor (PAF) antagonists.
    Dive G; Godfroid JJ; Lamotte-Brasseur J; Batt JP; Heymans F; Dupont L; Braquet P
    J Lipid Mediat; 1989; 1(4):201-15. PubMed ID: 2562434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure.
    Anderson BO; Bensard DD; Harken AH
    Surg Gynecol Obstet; 1991 May; 172(5):415-24. PubMed ID: 1851337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.